Danaher

Danaher announced a leadership change on August 3, 2026. Danaher’s Board appointed Diagnostics executive Julie Sawyer Montgomery as President and CEO, succeeding retiring CEO Rainer Blair, effective October 1, 2026.

What changed

Julie Sawyer Montgomery was named President and Chief Executive Officer. Rainer Blair will retire on October 1, 2026 and serve as a senior advisor until March 31, 2027 to ensure a seamless transition.

• Leader: Julie Sawyer Montgomery
• Role: President and Chief Executive Officer
• Effective: October 1, 2026
• Announcement date: August 3, 2026

Leadership background

Sawyer Montgomery has nearly 25 years of experience across healthcare, commercial operations, and R&D, the company said. She joined Danaher in 2017 at Beckman Coulter Diagnostics, where she led commercial operations and R&D before becoming President in 2020. She most recently served as Executive Vice President with responsibility for the Diagnostics platform, which the company said grew from approximately $6.0 billion in revenue in 2017 to approximately $11.0 billion today.

The mandate

In the announcement, Sawyer Montgomery said there is an opportunity to unleash the full power of Danaher as the company accelerates innovation, enhances its business capabilities, and more effectively leverages the Danaher Business System across its businesses.

Why this matters for GTM teams

Executive appointments can precede changes in strategy, operating cadence, hiring, partnerships, and technology priorities. The useful signal is not the title alone: teams should watch the new leader’s stated mandate, prior playbook, organizational scope, and the initiatives announced during the first two quarters.

Source and methodology

This leadership profile is based on the company’s announcement. Roles, transition timing, and biographical details are presented as announced; SalesTools Research does not infer undisclosed succession plans.

Primary source: Danaher leadership announcement.